Patents
Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
05/2010
05/19/2010EP2186830A1 Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof
05/19/2010CN101113457B Method for synthesizing arginine-enriched polypeptide-gold nano particle cell transmission carrier
05/18/2010US7718845 Production of growth hormone in the milk of a transgenic bovine and methods of purification of the growth hormone from the milk
05/18/2010US7718772 Canine thymic stromal lymphopoietin protein and uses thereof
05/18/2010US7718617 Using tissue preservation solution ( kallikrein inhibitor ) to decrease reperfusion injury of an organ during surgery and/or following removal of organ
05/18/2010US7718383 Human T2R65 taste receptor and related assays for identifying human bitter taste modulators
05/18/2010US7718173 Anti-pro6094 antibodies
05/17/2010CA2686135A1 Chimeric hirudin proteins
05/14/2010WO2010051632A1 Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation
05/14/2010CA2742528A1 Apj receptor compounds
05/14/2010CA2742509A1 Cxcr4 receptor compounds
05/14/2010CA2689726A1 Antibodies against gpi.alpha.
05/13/2010US20100119529 Elastin-like polymer delivery vehicles
05/13/2010US20100119501 Method of delivering a protein into a cell
05/12/2010EP2184356A1 Method of binding protein to support using tamavidin
05/12/2010CN1911447B Transferrin-polyethylene glycol medicine molecular compound, and used of medicine prepared by the same
05/12/2010CN1738643B Composition and method for preventing or treating a virus infection
05/11/2010US7714109 antibody, immunoconjugate and duramycin-based compositions; bind and inhibit anionic phospholipids and aminophospholipids, for use in the safe and effective treatment of cancer, viral infections and related diseases
05/11/2010CA2395254C Branched polyalkylene glycols
05/06/2010WO2010051347A1 A method for cardioprotection
05/06/2010US20100113753 Methods for preparing T-cells for cell therapy
05/06/2010US20100112546 Nanoscale sensors
05/06/2010US20100111979 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
05/06/2010CA2742064A1 Materials and methods relating to stem cell mobilization by multi-pegylated granulocyte colony stimulating factor
05/05/2010CN1687152B Carrier of separating amino acid and preparation method thereof
05/04/2010US7709607 solubility of the variant is improved by at least 3-fold relative to residues 110-244 of human adiponectin; increased soluble expression and stability, lower immunogenicity, and improved pharmacokinetics and/or pharmacodynamics
05/04/2010US7709603 PRO1190 polypeptides
05/04/2010US7709237 Crystal structure of CMY-10, a β-lactamase causing antibiotic resistance with extended-substrate spectrum
04/2010
04/29/2010WO2010047419A1 Immobilization substrate and method for producing the same
04/29/2010US20100105880 Purification of carbon nanotubes via biomolecules
04/28/2010CN1837239B Polypeptide growth factor copolymer and its preparation method and use
04/27/2010USRE41287 Cyclic agonists and antagonists of C5A receptors and G Protein-coupled receptors
04/27/2010USRE41286 cartilage regeneration and repair product that induces cell ingrowth into a bioresorbable material and cell differentiation into cartilage tissue; comprises at least one TGF beta protein and at least one bone morphogenetic protein
04/27/2010US7705120 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
04/27/2010US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer
04/27/2010US7704698 Human T2R51 taste receptor and related assays for identifying bitter taste modulators
04/27/2010US7704697 Nucleotide sequences coding protein 2A1of legionella for us as tool in diagnosis, prevention and treatment of legionnaires disease
04/27/2010US7704496 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
04/22/2010WO2010043057A1 Bsa-specific antibodies
04/22/2010US20100099779 Biocompatible material composition adaptable to diverse therapeutic indications
04/22/2010US20100099575 Novel polypeptide scaffolds and use thereof
04/22/2010CA2740561A1 Bsa-specific antibodies
04/21/2010EP1635692B1 Monitoring immunologic, hematologic and inflammatory diseases
04/21/2010CN101240026B Conjugate constructed from normal tridecyl and RGD peptide, and its synthesis and application in medicine
04/21/2010CN101062950B Polyethylene glycol modified thymus peptide 1 derivative
04/20/2010US7700736 PRO350 antibodies
04/20/2010US7700724 Mixture comprising serum complement system protein (INSP163) use in preparation of vaccines and antibodies for treatment and prevention of infection, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders
04/20/2010US7700719 Mutant protofibril for active immunisation; synuclein genes, proteins; point mutations; Parkinson's disease; dementia; host cells
04/20/2010US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides
04/20/2010US7700318 polypeptide comprising a TNF neutralizer domain, an IL-1 receptor antagonist domain, and a dimerization domain; rheumatoid arthritis or psoriasis
04/20/2010US7700303 Biosensors, method for obtaining the same and uses thereof
04/20/2010US7700276 pulsing blood cells present in the whole blood sample of step with an identical/similar and/or different immunomodulatory agent as present in the subject using a device or kit; diagnosis/prognosis/monitoring of a clinical status affecting the immune system
04/20/2010US7700272 Ligand gated chloride channel for use as screening tool in identifying/screening pesticidal and antiparasitic agents
04/20/2010CA2417207C Dental products comprising bone growth enhancing peptide
04/20/2010CA2377468C Peptide acceptor ligation methods
04/15/2010WO2009158657A3 Molecularly imprinted polymers for detecting microorganisms
04/15/2010US20100093933 Substituted Guar Protein Extracts and Production/Applications Thereof
04/15/2010US20100092567 Immunostimulatory nanoparticles and related compositions, methods and systems
04/15/2010US20100092508 Molecular Antigen Arrays
04/15/2010US20100092505 Method for Shielding Functional Sites or Epitopes on Proteins
04/14/2010EP0964693B1 Novel bacteriocins, transport and vector system and method of use thereof
04/14/2010CN101694494A Method for manufacturing micro-cantilever modified with antibody
04/14/2010CN101693021A Organic/inorganic hybridized microcapsule prepared in biomimetic way by simulated body fluid method and preparation method thereof
04/13/2010US7696340 Nucleotide and amino acid sequences from Xenorhabdus and uses thereof
04/13/2010US7696329 Immunoglobulin peptides against heated bovine blood
04/13/2010US7696319 PRO1772 antibodies
04/13/2010US7696307 inhibiting cell growth and metastasis and treat cancer ; A Disintegrin And Metalloproteinase with ThromboSpondin motifs (ADAMTS)
04/13/2010US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder
04/13/2010US7695905 Magnetic fine particles having lower critical solution temperature
04/13/2010CA2348773C Functional antagonists of hedgehog activity
04/13/2010CA2077154C Hcmv-specific peptides, agents therefor and the use thereof
04/08/2010US20100087621 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
04/07/2010EP2172208A1 Small peptides for the treatment of Alzheimer's disease and other Beta-Amyloid protein fibrillogenesis disorders
04/06/2010US7691990 Employs a procedure in which a DNA intercalator contained in liquid or gas is selectively adsorbed onto DNA by contacting the DNA with the DNA intercalator; capable of selectively adsorbing dioxin and dioxin-like substances with high efficiency and of easily enhancing throughput
04/06/2010US7691976 BRAF35 protein and BRCA2/BRAF35 complex and methods of use
04/06/2010US7691971 Protein NMB1125 and use thereof in pharmaceutical formulations
04/06/2010US7691806 Mixture of protein polymer and active materials
04/06/2010US7691385 Polypeptides encoded by polynucleotides that are useful for detecting resistance to streptogramin A or to streptogramin B and related compounds
04/01/2010US20100080798 Kim-1 antagonists and use to modulate immune system
03/2010
03/31/2010EP2168975A2 Stable protein storage and stable nucleic acid storage in recoverable form
03/31/2010CN101687908A Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof
03/30/2010US7687606 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil.
03/25/2010US20100075441 Rapid immunochromatographic detection by amplification of the colloidal gold signal
03/24/2010EP2165758A1 Porous carrier having formyl group, absorbent using the porous carrier, method for production of the porous carrier, and method for production of the absorbent
03/24/2010CN101679502A A new type of consensus interferon and preparation method thereof
03/24/2010CN101679500A G-protein-conjugated receptor having altered ligand affinity, and use thereof
03/24/2010CN101678093A Vaccine for the prevention of breast cancer relapse
03/24/2010CN101677537A disintegrin variants and pharmaceutical uses thereof
03/23/2010CA2290724C Glycopeptide hexapeptides
03/18/2010WO2009137145A3 Transcriptional control in alicyclobacillus acidocaldarius and associated genes, proteins, and methods
03/18/2010US20100069815 Substrate for biological fluid treatment
03/18/2010US20100069607 Method of covalently linking a carbohydrate or polyalkylene oxide to a peptide, precursors for use in the method and resultant products
03/18/2010US20100068255 liposomes comprising humanized Fab fragment of monoclonal antibody that binds cell surface markers, amphipathic vesicle-forming lipid and polyethylene glycol derivatized lipid, capable of inhibiting growth and proliferation of target cells; HER growth factor receptors
03/17/2010CN101671395A Method for quickly immobilizing proteins or amino-contained molecules on aminated surface
03/16/2010US7678886 increased recombinant protein expression levels, solubility, soluble expression and stability, lower immunogenicity, and improved pharmacokinetics and/or pharmacodynamics
03/16/2010CA2368617C Hydrogel-forming system with hydrophobic and hydrophilic components
03/11/2010WO2009122227A3 Treating cerebrovascular diseases with erythropoietin and granulocyte-colony stimulating factor jointly
03/11/2010US20100063135 Polyethylene glycol lipid conjugates and uses thereof
03/11/2010US20100062417 Zeolite crystals with biological material
03/11/2010US20100062007 Multi-modal cancer therapy using viral hitch-hiking
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 107